Paras Healthcare IPO: Occupancy Rates and Execution Under Analyst Scrutiny

Paras Healthcare IPO: Analysts Highlight Occupancy and Execution as Key Factors

As Paras Healthcare opens its ₹1,450 crore IPO, analysts are closely monitoring occupancy rates and execution capabilities, which are pivotal for the company’s growth trajectory.

Brokerage Insights on the IPO

SBI Securities has assigned a Neutral rating to the IPO, emphasizing that while Paras Healthcare is well-positioned to benefit from the increasing demand for healthcare services, several factors warrant close attention. The brokerage notes that growth is likely to be driven by rising occupancy rates in new hospitals, expansion into high-acuity specialties, and planned capacity additions in Gurugram and Ludhiana. However, the company’s significant reliance on government schemes and public sector unit (PSU) patients, along with regulatory and pricing uncertainties, poses potential risks.

SBI’s report highlights a notable improvement in operational metrics, with bed occupancy increasing to 61.8% in FY26 from 50.8% in FY25, and occupied bed days growing by 25.8% year-on-year. This uptick reflects stronger patient throughput and better utilization of existing infrastructure, suggesting that the company can expand without significant capital investment.

Positive Outlook from Ventura

In contrast, Ventura has issued a ‘Subscribe’ rating for the IPO, citing the company’s potential for brownfield expansions at existing facilities. The firm has acquired land adjacent to its Panchkula facility for future growth and is open to evaluating inorganic opportunities that could enhance regional scale or operational leverage. Ventura emphasizes that Paras Healthcare’s focus on high-acuity specialties—such as cardiac sciences, oncology, and orthopedics—positions it well in markets where organized private healthcare penetration remains low.

IPO Details and Subscription Status

The Paras Healthcare IPO is structured as a book-built issue, comprising a fresh issue of 72.15 lakh shares worth ₹500 crores and an offer for sale of 1.37 crore shares totaling ₹950 crores. The price band for the shares is set between ₹660 and ₹693, with a minimum investment of ₹14,553 required for individual investors. As of 12:20 PM on the opening day, the IPO was subscribed 0.09 times overall, with the retail category seeing a subscription of 0.43 times and no bids recorded in the Qualified Institutional Buyer (QIB) category.

Key Considerations for Investors

Investors should remain vigilant regarding the occupancy rates and execution capabilities of Paras Healthcare as these factors will significantly influence the company’s performance post-listing. The mixed ratings from brokerages reflect a broader uncertainty in the healthcare sector, driven by regulatory challenges and the economic landscape. As such, potential investors are advised to weigh these considerations carefully before making investment decisions.

Key Highlights

• Paras Healthcare’s IPO is valued at ₹1,450 crores, with a price band of ₹660 to ₹693 per share.
• SBI Securities assigns a Neutral rating, citing high dependence on government schemes as a risk factor.
• Ventura gives a ‘Subscribe’ rating, highlighting potential for brownfield expansions.
• Bed occupancy improved to 61.8% in FY26, indicating stronger operational metrics.
• The IPO was subscribed 0.09 times overall as of midday on the opening day.

Investor Note: As the Paras Healthcare IPO unfolds, investors should closely monitor occupancy rates and execution capabilities, which are critical for the company’s growth and stability in a competitive healthcare landscape.